Jubilant Biosys

The decision makers in Jubilant Biosys are Balaji Vn, Bob Dougherty, Gopala Krishna, etc. Click to Find Jubilant Biosys decision makers emails.

Jubilant Biosys provides a comprehensive range of services in drug discovery, including Structural Biology, Medicinal Chemistry, Computational Chemistry, and both in-vitro and in-vivo Biology. Their expertise extends to DMPK (Drug Metabolism and Pharmacokinetics) and Toxicology, allowing them to support clients throughout the entire drug development process, from target identification to preclinical studies.

Jubilant Biosys adheres to stringent regulatory standards by operating under Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) guidelines. They are also accredited by AAALAC and CPCSEA, ensuring that their research practices meet the highest ethical and scientific standards. This commitment to compliance helps clients navigate the complex regulatory landscape of drug development.

Jubilant Biosys primarily serves the pharmaceutical and biotechnology industries. Their services cater to a wide range of clients, including small biotech firms, large pharmaceutical companies, and academic institutions. By providing tailored solutions in drug discovery and development, they help these organizations bring innovative therapies to market.

Yes, Jubilant Biosys offers extensive capabilities in both in-vitro and in-vivo studies. Their in-vitro services include various assays to evaluate drug efficacy, while their in-vivo services encompass efficacy and pharmacodynamics (PD) models. This dual approach allows clients to gain a comprehensive understanding of their drug candidates' performance in both laboratory and biological settings.

DMPK and Toxicology are critical components of the drug development process at Jubilant Biosys. DMPK studies assess the absorption, distribution, metabolism, and excretion (ADME) of drug candidates, helping to predict their behavior in the human body. Toxicology studies evaluate the safety profile of these candidates, identifying potential adverse effects. Together, these services ensure that only the most promising and safe drug candidates progress to clinical trials.

To get in touch with Jubilant Biosys for a consultation, you can visit their official website at http://www.jubilantbiosys.com and fill out the contact form provided. Alternatively, you can reach out via their listed phone numbers or email addresses for direct inquiries. Their team is ready to discuss your specific needs and how they can assist in your drug discovery and development projects.